Pricing pressures have become the new normal for the pharmaceutical industry. Three main factors are forcing down drug prices: government pressure, patent losses and the rise of generics. In developed markets, governments account for nearly 76% of spending on hospitals and other medical services.
Consumers facing complex health conditions that are treated by specialty medications don’t need more ads.
There is no question that consumer shopping behavior is forcing brick-and-mortar retailers, e-commerce providers and consumer packaged goods companies to look for new growth opportunities and ways of providing differentiated shopping and brand experiences.
The NACDS Retail Advisory Board’s Market Immersion series resembles a microcosm of the NACDS Total Store Expo, in that the topics discussed emphasize the interrelationships of virtually every aspect of the business.
I grew up in a very small town, Yardley, Pa., in the 1970s. Main Street, “downtown,” had only one pizza place (Vince’s), one convenience store (WaWa) and no movie theater. We did, however, have two drug stores less than 150 yards from each other. In the 20 years that I lived in
Physicians Robin Warren and Barry Marshall were practically laughed out of health care in 1982 when they suggested that a type of bacteria might be causing stomach ulcers. It took more than a decade before their theory that treating ulcers with antibiotics to kill H.
Amazon.com’s venture into the pharmacy market has finally been confirmed. On June 28, Amazon announced that it had entered into an agreement to buy U.S.-based online pharmacy PillPack.
For the pharmaceutical industry, and particularly drug store retail chains like CVS Pharmacy and Walgreens, Amazon.com is about to become a headache that not even the strongest pain meds can cure.
Health care economists, health system leaders and policy makers have been talking seriously about measuring and paying for value in health care for more than a decade.
NEW YORK – Few industries have escaped the radical shifting of landscape that has been the collateral damage of digitization.
A year after announcing it was acquiring Whole Foods Market, Amazon.com made a splash again, this time in the health care sector.
Thanks to the ever-growing applications of data analytics technology, chain drug stores have a unique opportunity to create benefits ranging from improved member outcomes to lowered spending.
Reverse distribution of pharmaceutical products accounts for 3.5% to 4% of all pharmaceutical sales — more than 120 million product units — and exceeds $13 billion in value, according to a new report from the Healthcare Distribution Alliance (HDA) Research Foundation.
Amazon’s long anticipated, much ballyhooed entry into the retail pharmacy sector has finally taken place.
All indications are that CVS Health’s $77 billion acquisition of Aetna is on track to be finalized by the end of the year.
With e-commerce capturing a growing slice of the retail pie, the future of the physical store becomes a more urgent question.
